Human cIAP-1/HIAP-2 Antibody, R&D Systems™

cIAP-1/HIAP-2

Monoclonal

LYOPH

Immunohistochemistry 8-25 ug/mL

Q13490

BIRC2

E. coli-derived recombinant human cIAP-1/HIAP-2 His2-Ser618 Accession # Q13490

25 μg

Primary

Detects human cIAP-1/HIAP-2 in direct ELISAs. In direct ELISAs, 25% cross-reactivity with recombinant human cIAP-2 is observed.

Human

Purified

Immunohistochemistry

681724

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

API1Hiap-2, apoptosis inhibitor 1, baculoviral IAP repeat containing 2, baculoviral IAP repeat-containing 2, baculoviral IAP repeat-containing protein 2, BIRC2, cIAP1, C-IAP1, hIAP2, HIAP-2, IAP homolog B, IAP2, IAP-2, Inhibitor of apoptosis protein 2, MIHB, MIHBHIAP2, NFR2-TRAF signalling complex protein, RING finger protein 48, RNF48hiap-2, TNFR2-TRAF-signaling complex protein 2

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

329

Sterile PBS to a final concentration of 0.5 mg/mL.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1